Clinical Trial

Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary outcome is to evaluate the effect of Cynacol on the change in LDL-C levels compared to Metacol after 90 days of supplementation. The secondary outcomes are to evaluate: \- the change of TC, non-HDL cholesterol (non-HDL-C), apolipoprotein B (apoB), Tg, HDL-C levels after 90 days of supplementation with Cynacol compared to Metacol. The safety outcome is collection of the adverse events not related, related or possibly related to the study products.
Trial Details
NCT Number NCT07295327
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions Hypercholesterolemia
Enrollment 40 participants
Start Date 2025-09-30
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-19